Legal Notebook: Catalyst’s Suit vs. FDA Is Tossed, Avonex Patent Invalidity Verdict Is Reinstated

 
• By Brenda Sandburg
Courthouse Pillars & Stairs
District court dismisses suit agaisnt FDA while appeals court reverses Biogen win in multiple sclerosis drug patent dispute • Source: Shutterstock

More from US FDA

More from Agency Leadership